| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0009-8981(02)00046-3 |
| P698 | PubMed publication ID | 11983201 |
| P50 | author | Xavier Pintó | Q38801278 |
| P2093 | author name string | Juan Mañá | |
| Albert Salazar | |||
| Ramon Pujol | |||
| Isabel Hurtado | |||
| Josep Ma Argimón | |||
| P2860 | cites work | Computer-assisted design of studies using routine clinical data. Analyzing the association of prednisone and cholesterol | Q36459877 |
| Clinical factors predicting persistence of activity in sarcoidosis: a multivariate analysis of 193 cases | Q41052575 | ||
| Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. II. Effects of anti-inflammatory and disease-modifying drug treatment | Q41913088 | ||
| Hypocholesterolaemia and abnormal high-density lipoprotein in rheumatoid arthritis | Q41916840 | ||
| Effect of short-term, low-dose corticosteroids on plasma lipoprotein lipids | Q43591338 | ||
| Altered high density lipoprotein metabolism in patients with myeloproliferative disorders and hypocholesterolemia | Q44759669 | ||
| Are the pulmonary function tests and the markers of activity helpful to establish the prognosis of sarcoidosis? | Q50997455 | ||
| High-density lipoprotein cholesterol is reduced in patients with sarcoidosis. | Q51656377 | ||
| Elevated Apolipoprotein-B Levels in Corticosteroid-Treated Patients with Systemic Lupus Erythematosus* | Q68488659 | ||
| Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids | Q69414146 | ||
| Clinical significance of serum thermolysin-like metalloendopeptidase and its relationship to serum angiotensin converting enzyme in sarcoidosis | Q70159859 | ||
| Abnormalities in lipoprotein metabolism in Gaucher type 1 disease | Q70377700 | ||
| Dyslipoproteinemia in pediatric systemic lupus erythematosus | Q70396550 | ||
| The effects of prednisone therapy on plasma lipoproteins and apolipoproteins: a prospective study | Q71365801 | ||
| Value of serial measurement of serum angiotensin converting enzyme in the management of sarcoidosis | Q72877846 | ||
| Influence of serum amyloid A on the decrease of high density lipoprotein-cholesterol in active sarcoidosis | Q74348239 | ||
| Low levels of high density lipoprotein cholesterol in patients with active sarcoidosis | Q74527576 | ||
| P433 | issue | 1-2 | |
| P921 | main subject | hypoalphalipoproteinemia | Q5959167 |
| P304 | page(s) | 59-64 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | Clinica Chimica Acta | Q5133740 |
| P1476 | title | Corticosteroid therapy increases HDL-cholesterol concentrations in patients with active sarcoidosis and hypoalphalipoproteinemia | |
| P478 | volume | 320 |
| Q53653844 | Glucocorticoid use is associated with increase in HDL and no change in other lipids in rheumatoid arthritis patients. |
| Q38293477 | Impact of systemic inflammation and autoimmune diseases on apoA-I and HDL plasma levels and functions |
| Q36802963 | Low-dose dexamethasone administration for 3 weeks favorably affects plasma HDL concentration and composition but does not affect very low-density lipoprotein kinetics. |
| Q42291117 | SNP Variants in Major Histocompatibility Complex Are Associated with Sarcoidosis Susceptibility-A Joint Analysis in Four European Populations |
| Q91741505 | SpotLight Proteomics-A IgG-Enrichment Phenotype Profiling Approach with Clinical Implications |
| Q34075414 | Unusual pattern of dyslipidemia in children receiving steroid minimization immunosuppression after renal transplantation |
Search more.